Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Evaluator Blinded, Split-hand Study to Evaluate the Effectiveness and Safety of Restylane Lyft With Lidocaine Compared to no Treatment for Injection in the Dorsal Hand to Correct Volume Deficit

NCT02650921 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT02650921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02650921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Evaluator Blinded, Split-hand Study to Evaluate the Effectiveness and Safety of Restylane Lyft With Lidocaine Compared to no Treatment for Injection in the Dorsal Hand to Correct Volume Deficit
Lead sponsor
Galderma R&D
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2015
Completion date
December 31, 2016
Enrollment
92 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

volume deficit in the hand